Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Articles

Page Path
HOME > Clin Endosc > Volume 59(5); 2026 > Article
Letter to the Editor Real-world computer-aided detection for adenoma detection: promising but context-dependent
Yunho Jungorcid
Clinical Endoscopy 2026;59(5):870-871.
DOI: https://doi.org/10.5946/ce.2026.330
Published online: September 15, 2026

Division of Gastroenterology, Department of Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea

Correspondence: Yunho Jung Division of Gastroenterology, Department of Medicine, Soonchunhyang University College of Medicine, 31 Soonchunhyang 6-gil, Dongnam-gu, Cheonan 31151, Korea E-mail: yunho7575@gmail.com
• Received: July 4, 2026   • Revised: July 22, 2026   • Accepted: July 29, 2026

© 2026 Korean Society of Gastrointestinal Endoscopy

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 540 Views
  • 28 Download
prev next
With great interest, we read the article by Rønborg et al.,1 who evaluated the real-world effect of computer-aided detection (CADe, GI Genius; Medtronic) on adenoma detection rate (ADR)—an outcome previously reported to improve in pooled analyses of randomized controlled trials2—in a prospective observational study with a concurrent comparator group. This design is more rigorous than those of many previous real-world CADe studies that relied on historical controls, and we commend the authors for the pragmatic approach. The authors found only a modest, statistically nonsignificant increase in ADR with CADe use (34.7% vs. 30.5%; risk ratio, 1.12; 95% confidence interval, 0.88–1.43), suggesting that the real-world benefit of CADe may be limited. We would like to raise a few points regarding the study design that may have contributed to this nonsignificant finding.
It should be noted that no mucosal exposure device (e.g., Endocuff Vision) was used in either study arm. Both a randomized trial and a real-world retrospective study have shown that combining GI Genius with a mucosal exposure device significantly increases ADR compared with GI Genius alone,3,4 raising the possibility that the absence of such a device may have limited the ceiling of achievable benefit in the present cohort.
The CADe module was available for only three months, the same duration used for patient enrollment, providing little time for endoscopists to become familiar with the system and calibrate their reliance on its prompts. In contrast, real-world evaluations in which endoscopists had several months of prior experience with a CADe system before formal assessment have reported significant ADR gains,5,6 suggesting that the degree of prior exposure to a specific system, rather than its mere availability, may be an important and under-reported variable.
Moreover, the median Boston bowel preparation scale score was 6, which is generally considered adequate rather than excellent bowel preparation. Since a CADe system can only flag lesions within the mucosa that has already been exposed and adequately cleansed,7 the inclusion of patients with suboptimal bowel preparation may have diluted the apparent benefit of CADe in the overall analysis.
Additionally, patients and endoscopists were not blinded to CADe system use, which the authors acknowledge as a potential source of bias. Unblinded, real-world CADe cohorts elsewhere have shown numerically lower ADR with artificial intelligence (AI) assistance, an effect attributed to shortened procedural times and possible overreliance on the system.8 Whether such behavioral compensation contributed to the modest effect size observed in the present study remains an open question.
In summary, we congratulate the authors on a rigorous evaluation of CADe that appropriately tempers the expectations set by randomized trials. However, the real-world benefit of CADe may depend as much on the implementation context—including device combination, endoscopists’ cumulative experience with the specific system, bowel preparation quality, and endoscopists’ behavior—as on the underlying detection algorithm itself. Similar concerns regarding implementation and generalizability have been raised for other AI applications in endoscopy, including deep learning-based prediction of lymph node metastasis risk in T1 colorectal cancer, for which generalizability remains limited by dataset quality and single-institution training.9 We agree with Rey10 that realizing the full potential of AI in endoscopy will require moving beyond single-device or single-center evaluations toward larger, multicenter studies that systematically account for these practice-level variables.
  • 1. Rønborg SN, Ujjal S, Kroijer R, et al. Assessing the potential of artificial intelligence to enhance colonoscopy adenoma detection in clinical practice: a prospective observational trial. Clin Endosc 2024;57:783–789.ArticlePubMedPMCPDF
  • 2. Hassan C, Spadaccini M, Mori Y, et al. Real-time computer-aided detection of colorectal neoplasia during colonoscopy: a systematic review and meta-analysis. Ann Intern Med 2023;176:1209–1220.ArticlePubMed
  • 3. Spadaccini M, Hassan C, Rondonotti E, et al. Combination of mucosa-exposure device and computer-aided detection for adenoma detection during colonoscopy: a randomized trial. Gastroenterology 2023;165:244–251.ArticlePubMed
  • 4. Kim JH, Wang J, Pence C, et al. GI Genius increases small and right-sided adenoma and sessile serrated lesion detection rate when used with EndoCuff in a real-world setting: a retrospective United States study. Clin Endosc 2025;58:438–447.ArticlePubMedPMCPDF
  • 5. Park JB, Bae JH. Effectiveness of a novel artificial intelligence-assisted colonoscopy system for adenoma detection: a prospective, propensity score-matched, non-randomized controlled study in Korea. Clin Endosc 2025;58:112–120.ArticlePubMedPDF
  • 6. Repici A, Spadaccini M, Antonelli G, et al. Artificial intelligence and colonoscopy experience: lessons from two randomised trials. Gut 2022;71:757–765.ArticlePubMed
  • 7. Lai EJ, Calderwood AH, Doros G, et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc 2009;69:620–625.ArticlePubMedPMC
  • 8. Levy I, Bruckmayer L, Klang E, et al. Artificial intelligence-aided colonoscopy does not increase adenoma detection rate in routine clinical practice. Am J Gastroenterol 2022;117:1871–1873.ArticlePubMed
  • 9. Li JW, Wang LM, Ichimasa K, et al. Use of artificial intelligence in the management of T1 colorectal cancer: a new tool in the arsenal or is deep learning out of its depth? Clin Endosc 2024;57:24–35.ArticlePubMedPDF
  • 10. Rey JF. As how artificial intelligence is revolutionizing endoscopy. Clin Endosc 2024;57:302–308.ArticlePubMedPMCPDF

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  

      • Cite
        CITE
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Real-world computer-aided detection for adenoma detection: promising but context-dependent
        Clin Endosc. 2026;59(5):870-871.   Published online September 15, 2026
        Close
      • XML DownloadXML Download
      Real-world computer-aided detection for adenoma detection: promising but context-dependent
      Real-world computer-aided detection for adenoma detection: promising but context-dependent

      Clin Endosc : Clinical Endoscopy Twitter Facebook
      Close layer
      TOP